Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
210
datasets available to search
ShareScore release 0.9.0
Dataset results
210 results for “Ebola”
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
ClinicalTrials.gov study NCT02718469. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)
ClinicalTrials.gov study NCT02503202. IPD Sharing: YES. Countries: 0. Publications: 4.
A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
ClinicalTrials.gov study NCT02376426. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)
ClinicalTrials.gov study NCT02280408. IPD Sharing: YES. Countries: 0. Publications: 2.
Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
ClinicalTrials.gov study NCT02333578. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia
ClinicalTrials.gov study NCT05888649. IPD Sharing: NO. Countries: 1. Publications: 10.
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)
ClinicalTrials.gov study NCT02269423. IPD Sharing: YES. Countries: 0. Publications: 2.
Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
ClinicalTrials.gov study NCT02354404. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)
ClinicalTrials.gov study NCT04409405. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo
ClinicalTrials.gov study NCT02240875. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia
ClinicalTrials.gov study NCT06811129. IPD Sharing: NO. Countries: 1. Publications: 10.
EBOla Post-Exposure Prophylaxis
ClinicalTrials.gov study NCT06841614. IPD Sharing: NO. Countries: 4. Publications: 13.
Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
ClinicalTrials.gov study NCT04152486. IPD Sharing: YES. Countries: 1. Publications: 1.
Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)
ClinicalTrials.gov study NCT02314923. IPD Sharing: YES. Countries: 0. Publications: 2.
A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
ClinicalTrials.gov study NCT02313077. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response
ClinicalTrials.gov study NCT03098862. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From
ClinicalTrials.gov study NCT02295501. IPD Sharing: Not stated. Countries: 1. Publications: 1.
VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Hea
ClinicalTrials.gov study NCT02408913. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
ClinicalTrials.gov study NCT02739477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
ClinicalTrials.gov study NCT02376400. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.